PBMC Collection and iPSC Reprogramming
At Greenstone Biosciences, we collect peripheral blood mononuclear cells (PBMCs) from patients or healthy donors and reprogram them into induced pluripotent stem cells (iPSCs). These iPSCs provide an unlimited, renewable, and genetically faithful cell source that captures each donor’s unique genetic background.
Personalized Cellular Models
Our platform enables researchers to build patient-specific models of disease, drug response, and therapeutic development. By starting with PBMCs, we ensure a minimally invasive collection process while preserving maximum biological relevance.
Versatile and Scalable Research Tool
Greenstone’s PBMC-to-iPSC workflow supports a wide range of applications:
Reliable and Reproducible
Our standardized protocols and advanced reprogramming techniques deliver robust, high-quality iPSC lines suitable for longitudinal studies and high-throughput applications.
Empowering Precision Research
By combining minimally invasive sample collection with cutting-edge iPSC technology, Greenstone Biosciences enables researchers to accelerate discoveries and develop more predictive, patient-relevant therapeutics.
Get Started with PBMC Reprogramming
Advance your disease modeling, drug discovery, and regenerative medicine research with our PBMC-to-iPSC platform.